Back to Portfolio
DNOW

DNOW Inc.

$13.23 2.5B market cap 2026-06-06 |
DNOW Inc. DNOW BUFFETT / MUNGER / KLARMAN SUMMARY
1 SNAPSHOT
Price$13.23
Market Cap2.5B
2 BUSINESS

DNOW is a capital-light energy/industrial PVF distributor that doubled in size via the November 2025 all-stock MRC Global merger, diversifying toward more durable midstream, gas-utility, and data-center demand. The merger temporarily wrecked GAAP optics (FY2025 net loss, $135M inventory step-up, ERP friction, first-ever debt, suppressed FCF), creating a complexity-driven mispricing that Klarman's Baupost took a 0.84% starter position in. But valuing the combined business on normalized, through-cycle owner earnings, my methods converge on roughly $8-13 per share, placing $13.23 at the top of fair value with no margin of safety. The market already pays for flawless integration plus the 2027 synergy target plus a mid-cycle energy backdrop. A 3-year expected-return tree is mildly negative at today's price and only turns attractive on a 25-35% pullback. Good business, good operator, sensible deal - but the price has not yet fallen to where the risk/reward pays me to underwrite the integration.

3 MOAT NARROW

~300-location North American PVF network, integrated/VMI managed-supply contracts, MRCGO/DigitalNOW e-commerce, #1 energy PVF distributor post-MRC merger

4 MANAGEMENT
CEO: David Cherechinsky

Good - disciplined net-cash history, 26 tuck-in acquisitions, logical scale merger, $167M buybacks since 2022 ($50M record Q1-2026) explicitly at a discount to intrinsic value; no dividend (correct for a cyclical)

5 ECONOMICS
-0.3% Op Margin
9% ROIC
8.5% ROE
0.13B FCF
20% Debt/EBITDA
6 VALUATION
FCF Yield7.4%
DCF Range9 - 13

Overvalued ~20% vs base fair value $11; no margin of safety at $13.23

7 MUNGER INVERSION
Kill Event Severity P() E[Loss]
Integration/ERP failure on the MRC Global merger causing permanent customer and margin loss plus goodwill/intangible impairment HIGH - -
Prolonged energy-capex downturn compressing thin distribution margins on newly levered balance sheet MED - -
8 KLARMAN LENS
Downside Case

Integration/ERP failure on the MRC Global merger causing permanent customer and margin loss plus goodwill/intangible impairment

Why Market Right

Energy-capex downturn cratering volumes on newly levered balance sheet; Customer defection during ERP disruption becoming permanent; Goodwill or intangible impairment confirming merger overpayment

Catalysts

ERP stabilization and SAP migration unlocking margin recapture and visible inventory (2026-2027); Synergy realization: ~$30M year-1 run-rate, $70M three-year target; Working-capital release of ~$150M (inventory + AR) funding deleveraging in H2 2026; Secular midstream / gas-utility / data-center demand offsetting upstream cyclicality; Aggressive buybacks at management-stated discount to intrinsic value

9 VERDICT WAIT
B- Quality Moderate - first-ever debt (net $455M, 2.3x TTM EBITDA) but capital-light with counter-cyclical working-capital release; target 1-2x leverage by YE2026
Strong Buy$7.5
Buy$9
Fair Value$13

Wait. Accumulate ~$9.00; buy aggressively ~$7.50 (strong buy). Avoid above ~$13. Fair value $11.

🧠 ULTRATHINK Deep Philosophical Analysis

DNOW — Ultrathink Analysis

The Real Question

The surface question is "did Klarman find a bargain in DNOW?" The real question is deeper and more uncomfortable: what is the through-cycle earning power of a commodity distributor that just doubled its size by buying its largest competitor — and how much of that earning power is durable versus borrowed from a temporarily favorable point in the energy cycle?

Distribution is one of the most seductive traps in value investing. It looks capital-light (low capex, high inventory turns), it generates real cash, and "scale" sounds like a moat. But the brutal truth is that PVF distribution is the business of buying pipe and valves from manufacturers and selling them to drillers and utilities at a markup, and there is almost nothing — no patent, no brand premium, no network lock-in — that stops the customer from calling the other distributor. The real capital-allocation question is whether DNOW management is compounding shareholder wealth or simply running faster on a cyclical treadmill, and whether $1.76B was a brilliant consolidation or an empire-building overpay near a cyclical top.

Hidden Assumptions

The market's assumptions (possibly wrong):

  • That the 2027 EBITDA "marching order" of $350M is achievable — and that it deserves a normalized multiple now, before a single synergy has been proven in audited results.
  • That the ERP disaster is transitory friction, not permanent customer loss. The data is ambiguous: MRC US revenue fell 16% YoY, "concentrated across two dozen customers." Were those customers lost to the ERP mess, or to a real cyclical/competitive shift? The bull says the former (recoverable); the bear says the latter (gone).
  • That a debt-funded buyback near a cyclical bottom is value-accretive. It is — if the cycle has truly bottomed. If oil capex rolls over, management will have levered up to buy stock that then halves.

My own assumptions (which I must distrust):

  • That $330M of normalized EBITDA is the right anchor. I split the difference between FY2026 guidance ($225M) and the 2027 target ($350M). If I am anchoring too high, fair value drops toward $8–9 and even my "accumulate at $9" looks generous.
  • That distributors reliably release working capital in downturns. History (2020 OCF +$189M) supports this, but the combined entity's working capital is now $2.3B of inventory + receivables — a much bigger, less-tested machine.

The Contrarian View

For the bears to be completely right, the following must be true: PVF distribution is a structurally low-return commodity business with no pricing power; the MRC merger was a defensive scale grab in a shrinking energy-services pie, not a growth move; the synergies are mostly cost-cutting that competitors will compete away in price; the ERP-driven customer losses are permanent; and the energy cycle is closer to a top than a bottom, so the "trough EBITDA" the bulls are normalizing up from is actually closer to mid-cycle. In that world, normalized EBITDA is ~$250M not $350M, the multiple compresses to 6–7x because the market stops believing the growth story, and the levered equity falls to $7–8. The steelman is genuinely strong — this is why I refuse to pay up. The bear case is not a fringe view; it is the default outcome for most distribution roll-ups, and the burden of proof is on the bull.

Simplest Thesis

A good but cyclical, capital-light #1 distributor mid-way through a value-creating merger is trading at fair value, so the only sensible move is to wait for the integration risk to be priced in — at roughly $9 or below — before buying.

Why This Opportunity Exists

The mispricing exists because the situation is legible to a screen but illegible to a screener's logic. A quantitative filter sees FY2025: a net loss, negative free cash flow, leverage where there used to be net cash, no dividend, EPS of –$1.19 — and ejects the name. A human sees a transition year deliberately uglified by purchase accounting ($135M inventory step-up, $45M/yr non-cash amortization) on top of one-time merger and ERP costs. The gap between the GAAP headline and the normalized cash earning power is exactly the inefficiency. Add forced selling from former MRC holders who never chose DNOW, and the energy-sector stigma that keeps generalist capital away, and you get a stock that looks broken. Klarman's Baupost specializes in precisely this: post-merger, post-spin, special-situation complexity where patient capital can hold through the noise. But — and this is the crucial second-order insight — the inefficiency has already substantially corrected. The stock is at $13.23, near fair value, not at $7. The opportunity to buy the mispricing existed; today you would mostly be paying for the resolution.

What Would Change My Mind

Concrete, falsifiable triggers that would move me to buy (thesis confirmation):

  • Two consecutive quarters of combined gross margin recovering toward 22%+ after ERP stabilization, proving margin recapture, not permanent erosion.
  • Audited evidence of ≥$30M synergy run-rate landing on time, with net-debt leverage falling below 2x via the promised ~$150M working-capital release.
  • MRC US revenue stabilizing or recovering — the "two dozen customers" returning — confirming the losses were ERP friction, not competitive defeat.
  • Price falling to $9 (accumulate) or $7.50 (strong buy), creating the margin of safety regardless of the above.

Concrete triggers that would move me to reject/avoid permanently (thesis break):

  • A goodwill or intangible impairment charge (objective admission of overpayment).
  • Synergy guidance cut, or gross margin still declining a year after ERP stabilization.
  • Net-debt leverage climbing above 2.5x without a deleveraging path.
  • A new large debt-funded acquisition before this integration is digested — the unmistakable signature of a roll-up that has confused activity with value creation.

The Soul of This Business

Strip away the merger noise and the soul of DNOW is this: it is the connective tissue between the people who make the pipes, valves, pumps, and instruments and the people who build and maintain the physical infrastructure of energy and water. It exists because a Permian operator or a gas utility cannot economically stock 100,000 SKUs at every wellhead and substation — so they outsource that complexity to a distributor with 300 locations and deep manufacturer relationships. That is a real, useful, enduring function. The world will need PVF for decades; the merger smartly tilts the mix toward the more durable corners (gas utilities, midstream, LNG, data-center power infrastructure) and away from the boom-bust upstream casino.

But "useful and enduring" is not the same as "moated and high-return." This business will always be a price-taker on its products, a price-giver to its customers, and a hostage to the energy cycle. Its competitive position is inevitable enough to survive but fragile enough to never command a premium multiple. That is precisely why the discipline matters: a fair business like this rewards you handsomely only if you buy it cheap. Buffett would admire the operators, respect the deal logic, and then quietly wait for Mr. Market to offer it at a price that does the work for him. At $13.23, Mr. Market is being reasonable, not generous — and the value investor's edge is the patience to do nothing until he is generous.

1. Executive Summary

Three-sentence thesis. DNOW is a capital-light, net-cash-heritage energy and industrial PVF (pipe, valves, fittings) distributor spun from National Oilwell Varco in 2014 that, in November 2025, doubled its size via an all-stock merger with MRC Global — a transformational deal that diversifies it away from hyper-cyclical upstream drilling toward more durable midstream, gas-utility, and data-center demand. The merger has temporarily wrecked GAAP optics (FY2025 net loss, suppressed FCF, a $135M inventory fair-value step-up, ERP-integration friction, and the first balance-sheet debt in company history), creating exactly the kind of complexity-driven mispricing Seth Klarman's Baupost likely targeted with its new 0.84% Q1-2026 position. But when I value the combined business on normalized, through-cycle owner earnings, my methods converge on roughly $8–13 per share, placing the current $13.23 price at the top of fair value with no margin of safety — the market already pays for flawless integration plus the 2027 synergy target plus a mid-cycle energy backdrop.

Verdict: WAIT. Good business, good operator, sensible deal, real optionality — but the price has not yet fallen to where the risk/reward pays me to underwrite a cyclical mid-integration. I want a 25–35% discount to base fair value before committing capital.

Key metrics dashboard

Metric Value Note
Price / fair value (base $11) ~120% Modestly overvalued at $13.23
EV / normalized EBITDA ($330M) ~8.8x Fair, not cheap, for a cyclical distributor
EV / FY2026E EBITDA (~$225M) ~13x Optically expensive on trough/distorted year
P/B 1.10x Book $12.01; not a book-value bargain
P/Tangible book 2.33x TBV only $5.67 (goodwill+intangibles $1.18B)
Net debt / TTM EBITDA 2.3x First-ever leverage; target 1–2x by YE2026
ROE (5-yr avg, standalone) 8.5% Below Buffett's 15% bar; FY2025 negative
FCF yield (normalized owner earnings) ~7.4% Healthy if normalization is achieved
Dividend None All-buyback capital-return policy
Insider ownership ~1.7% Low; professional managers, not owner-operators

2. Phase 0 — Why does this opportunity exist? (Klarman)

A clear, namable reason for mispricing exists — the necessary precondition for a value bet:

  1. Merger complexity and a "broken" GAAP year. The MRC Global deal closed Nov 6, 2025. FY2025 reported results blend ~10 months of standalone DNOW with ~2 months of MRC, then layer on a $135M inventory fair-value step-up, transaction costs, change-of-control severance, and incremental purchase-accounting amortization, producing a GAAP net loss of $89M (EPS ~ –$1.19 TTM). A screen sees "loss-making, levered, no dividend" and passes; a careful reader sees a distorted transition year.
  2. Temporarily suppressed free cash flow. Management said it plainly on the Q1-2026 call: "our free cash flow is temporarily suppressed, and our stock is trading at what we believe is a meaningful discount to intrinsic value." Q1 historically consumes working capital; this Q1 also bore merger costs, producing –$95M operating cash flow.
  3. First-ever debt + cyclicality fear. A company famous for net cash took on debt (net debt $455M) to fund deal mechanics and buy back stock. Combined with an energy-capex slowdown (US rig counts down ~7% YoY), the tape looks risky.
  4. Index / forced-selling overhang. MRC Global holders received DNOW stock (0.9489 ratio) and some mechanically sell a name they did not choose to own. The stock is ~21% below its 52-week high.
  5. Superinvestor signal (context, not input). Baupost (Klarman) initiated a new 0.84% position in Q1 2026. I use this only as a "why does this exist" tell — the profile (post-merger, misunderstood, cash-generative once normalized, special-situation) is textbook Klarman. I do not treat it as a price target or a reason to buy.

Klarman test passed: I can explain why this is cheap-looking. That does not mean it is cheap enough.

3. Phase 1 — Risk Analysis (Inversion: "where will this die?")

3.1 How could this permanently lose 50%+?

  1. Integration / ERP failure (highest-probability impairment path). Two parallel ERP efforts run in parallel: stabilizing MRC's Oracle platform and migrating MRC locations onto DNOW's SAP. Management admits the Oracle system "has stabilized to a level that allows us to conduct business, though it has not yet optimized." MRC's US business is ~42% of consolidated revenue, and Q1 standalone MRC US revenue fell 16% YoY with "nearly all" of the decline "concentrated across two dozen customers" — a tell that ERP disruption drove customer defection during the changeover. If those customers do not return and SAP migration slips, the synergy case and the revenue base erode, and the $617M goodwill / $565M intangibles become impairment candidates. Probability of material value destruction: ~25–30%. Impact: –40% to –60%.
  2. A genuine, prolonged energy-capex downturn. Even post-diversification, 37% of US revenue is upstream and the business is levered to oil & gas operating and capital spend. A 2015–2016 or 2020-style collapse would crater volumes, compress already-thin margins (21–22% gross, low-single-digit EBITDA), and strain new leverage. Probability over 5 years: ~20–25%. Impact: –35% to –50%.
  3. Leverage in a cyclical trough. Net debt 2.3x TTM EBITDA is modest in absolute terms but new and sits on a cyclical EBITDA stream. If EBITDA halves before the working-capital release lands, leverage spikes toward 4–5x and the equity reprices. Mitigant: distributors release enormous cash in a downturn (OCF was +$189M in 2020 even as revenue fell). Probability of distress: low (~5–8%); the counter-cyclical working-capital release is a real, repeatedly demonstrated cushion.

3.2 The bear case, stated better than the bears

DNOW just paid $1.76B to buy a structurally similar, lower-margin, no-growth competitor at the top of a roll-up cycle, financed partly with its first-ever debt, and the deal's own pro-forma combined net income is a rounding-error ~$10M (2025) and ~$17M (2024) — meaning the combined company, before synergies, earns almost nothing on a GAAP basis. The market cap is ~$2.46B for an entity whose two halves together generated ~$10M of GAAP profit; the entire thesis rests on extracting $70M of synergies and re-rating cyclical EBITDA running at ~3.3% of revenue (Q1 trough). Distribution is a commodity business with no pricing power, customers who multi-source, and Amazon-Business-style digital threats; "scale" in distribution rarely converts to durable returns on capital. At 1.1x book and 2.3x tangible book you pay a premium to net assets for a low-return, cyclical, mid-integration commodity distributor — and the superinvestor's position is a tiny 0.84% toe-hold, not a conviction bet.

That bear case is strong. My rebuttal is the normalization math (Section 4), the counter-cyclical cash mechanics, and the genuine end-market mix-shift toward midstream/gas-utility/data-center demand — but I cannot dismiss it, and at $13.23 I am not paid to.

3.3 Non-price sell / avoid triggers

  • Two consecutive quarters of declining combined gross-margin % after ERP stabilization (lost pricing/share, not transition noise).
  • Synergy run-rate guidance cut, or year-1 synergies materially below the raised ~$30M figure.
  • Net-debt leverage rising above 2.5x without a clear working-capital-release path.
  • Goodwill or intangible impairment charge (objective confirmation of overpayment).
  • A large debt-funded acquisition before integration is complete (roll-up indiscipline).

4. Phase 2 — Financial Analysis & Valuation

4.1 The normalization problem (the analytical crux)

GAAP earnings are useless here for two offsetting reasons:

  • Overstated costs: $135M inventory step-up (FY2025) and ~$45M/yr non-cash purchase-intangible amortization depress reported earnings but are not recurring cash costs.
  • Real costs easy to wish away: new cash interest ($30M/yr), genuine integration spend ($4.5M/quarter ERP + temp labor), and MRC's structurally slightly lower margins.

So I value the combined, mid-cycle, post-synergy business on owner earnings, not the distorted transition year.

Owner-earnings build (base case, ~2027–2028 normalized):

Line $M Basis
Revenue ~5,300 Combined run-rate; mgmt FY2026 "approaching $5B", 2027 +~7%
Adjusted EBITDA 330 Between FY2026E (~$225M, 4.5%) and 2027 "marching order" ($350M, ~6.5%); I use ~6.2%
less real D&A (30) Capital-light distributor
less purchase-intangible amort (non-cash) (45) Added back to owner earnings
= EBIT 255
less cash interest (30) Net debt declining
= pre-tax 225
less tax @ 26% (59) Mgmt guide 26–27%
= net income ~166 ~$0.89/share
+ non-cash purchase amort 45
− maintenance capex (30)
= Owner earnings ~181 ~$0.97/share; ~7.4% yield on market cap

This is the bull-leaning normalized case. A conservative case ($280M EBITDA) yields $110M owner earnings ($0.59/sh); a fuller-recovery case ($360M+) yields $200M+ ($1.10/sh).

4.2 Valuation Trinity (Klarman)

(a) Liquidation / asset floor. Net current asset value (the assets are working capital for a distributor):

NCAV = Current assets − Total liabilities = $2,278M − $1,686M = $592M ⇒ $3.18/share

Tangible book value = Equity − Goodwill − Intangibles = $2,238M − $617M − $565M = $1,056M ⇒ $5.67/share

The floor is ~$3.20–5.70, far below the current price. No Graham-style asset bargain here — you pay 2.3x tangible book and 4.2x NCAV.

(b) Going-concern DCF. Two-stage, 10% discount rate, owner earnings growing 4% for five years then 2% terminal (year-1 OE held below the fully normalized ~$181M because the next 12–18 months remain partly suppressed; the stream ramps in):

Owner earnings (yr 1) Implied EV less net debt Equity / share
Conservative $110M ~$1,526M $455M ~$5.75
Base $140M ~$1,942M $455M ~$7.98
Bull $170M ~$2,358M $455M ~$10.21

(c) Private-market / EV-EBITDA cross-check. Distributors trade ~7–9x EBITDA through the cycle; the MRC deal itself was struck at a single-digit EBITDA multiple. Applying 7–9x to normalized EBITDA:

Normalized EBITDA 7x → /sh 8x → /sh 9x → /sh
$280M $8.08 $9.58 $11.08
$330M $9.96 $11.73 $13.50
$360M $11.08 $13.02 $14.95

4.3 Margin of safety table

Method Value/share vs $13.23
NCAV (floor) $3.18 –76% (pay 4.2x NCAV)
Tangible book $5.67 –57%
DCF conservative $5.75 –57%
DCF base $7.98 –40%
DCF bull $10.21 –23%
EV/EBITDA base ($330M @ 8x) $11.73 –11%
EV/EBITDA bull ($360M @ 9x) $14.95 +13%

Intrinsic value (weighted, leaning on DCF base + EV/EBITDA base, plus optionality): base fair value ~$11, reasonable range $9–13. Add $0.80/share of working-capital-release optionality ($150M inventory+AR unlock) and a successful-synergy scenario can justify the low-$13s — but that good outcome is already in the price.

Conclusion: At $13.23 the stock trades at ~120% of my $11 base fair value and is "cheap" only if you underwrite the bull EBITDA case at a full multiple. No margin of safety.

4.4 Returns & quality context

  • Standalone 5-yr average ROE ~8.5%; FY2025 ROE negative. A fair business, not a Buffett compounder — distribution earns mid-single to low-double-digit returns on capital, and only at mid-cycle.
  • Revenue 5-yr CAGR ~11.6% (acquisition-aided); organic growth is GDP-ish and cyclical.
  • Genuinely capital-light: capex ~$8–21M/yr against billions of revenue, so when it earns, it converts well to cash.

5. Phase 3 — Moat Analysis

Moat verdict: Narrow. DNOW has a scale-and-density advantage in PVF distribution, not a true economic moat.

Moat source Evidence Durability
Local density / ~300 locations National branch network near customer sites; same-day availability Real but replicable; merger widened this
Switching friction Integrated/managed-supply contracts, VMI, MRCGO/DigitalNOW e-commerce Moderate; sticky for managed accounts, weak for spot PVF
Supplier relationships / breadth Tens of thousands of SKUs, manufacturer connections (enabled ~$30M data-center orders) Moderate
Scale / purchasing Combined entity is clear #1 in energy PVF distribution post-merger Real cost edge, but distribution scale rarely earns >mid-teens ROIC

Erosion forces: digital/marketplace disintermediation (Amazon Business, direct-from-manufacturer), customer multi-sourcing, and the commodity nature of pipe/valves/fittings (Q1 showed margin given up to tariffs/freight).

Wider or narrower in 10 years? Modestly wider near-term (merger removes the #1 competitor and adds gas-utility/midstream density) but structurally narrow — never a pricing-power business. Munger: "a good-not-great business at a fair-not-cheap price."

6. Phase 4 — Management & Incentives

  • CEO David Cherechinsky (long-tenured ex-NOV/DNOW finance executive) and CFO Mark Johnson — professional managers, not founder-owners; insider ownership ~1.7% (low).
  • Capital allocation looks disciplined and rational. They (1) ran net cash for years, (2) made tuck-in acquisitions (Edge Controls was the 26th), (3) executed a large but logical scale merger, and (4) bought back $167M since late 2022, $50M in Q1 2026 alone (a record, 4.2M shares), explicitly because "our stock is trading at what we believe is a meaningful discount to intrinsic value." Buying back stock with debt for the first time is aggressive but defensible if their intrinsic-value estimate is right.
  • No dividend — 100% of capital return via buybacks + M&A. Correct policy for a cyclical (avoids a dividend you must cut in a downturn).
  • Healthy self-awareness: "M&A may not always represent the highest return of capital versus resolving U.S. ERP challenges and pursuing share repurchases." Signals they will not roll up for empire's sake.
  • Incentive caution: levering the balance sheet to buy back stock near a cyclical top while declaring it cheap raises the stakes — if the intrinsic-value call is wrong, the downside compounds.

7. Phase 5 — Catalysts

Catalyst Type Timeline Probability Impact
ERP stabilization → margin recapture Operational H2 2026 – 2027 High Medium-high
Synergy realization (~$30M yr-1, $70M 3-yr) Internal 2026–2028 Medium-high Medium
Working-capital release (~$150M cash) Internal H2 2026 Medium-high Medium (deleveraging)
Cyclical energy-capex recovery External 2026–2027 Medium High
Continued buybacks at discount Internal Ongoing High Medium
Midstream / gas-utility / data-center demand External Secular Medium-high Medium-high

Management states "the overall DNOW business has bottomed in 1Q 2026" and guides FY2026 revenue "approaching $5B", EBITDA "approaching 4.5%" (~$225M), and 2027 "marching orders" toward $350M EBITDA. These are real, near-dated catalysts — which is exactly why the market has already moved the price to fair value. Catalysts visible to everyone are usually priced.

8. Phase 6 — Synthesis, Sizing & Decision

8.1 Expected-return tree (3-year horizon, to fair value at exit)

Scenario Prob. Thesis 3-yr price Return
Bull 25% Full synergies, ERP optimized, mid-cycle EBITDA $360M+, re-rate to 9x $15–17 +20% to +30%
Base 45% Synergies mostly land, EBITDA ~$320–330M, fair multiple $11–13 –15% to flat
Bear 22% Integration drags, customer loss sticks, EBITDA ~$250M, multiple compresses $7–9 –35% to –45%
Disaster 8% Energy downturn + impairment + leverage stress $4–6 –55% to –70%

E[R] ≈ 0.25(+25%) + 0.45(−7%) + 0.22(−40%) + 0.08(−62%) ≈ −10.7% over three years at $13.23. A negative probability-weighted return confirms the price is too high for the risk; the math flips positive only on a materially lower entry.

8.2 What price would make this a buy?

  • Accumulate ($9.00): ~18% below base fair value of $11; roughly DCF-bull / EV-EBITDA-conservative crossover. Expected-return tree turns clearly positive and I am paid for integration risk.
  • Strong buy ($7.50): ~32% below base fair value; near DCF base, buying mid-cycle owner earnings at a single-digit multiple with the working-capital release as a free option.

8.3 Final recommendation

INVESTMENT RECOMMENDATION
Company: DNOW Inc.        Ticker: DNOW        Price: $13.23   Date: 2026-06-06
NCAV (floor)            $3.18    -76% (pay 4.2x)
Tangible Book           $5.67    -57%
DCF Conservative        $5.75    -57%
DCF Base                $7.98    -40%
EV/EBITDA Base (8x)     $11.73   -11%
EV/EBITDA Bull (9x)     $14.95   +13%
INTRINSIC VALUE (base): $11.00   (range $9-13)
MARGIN OF SAFETY @ $13.23:  NEGATIVE (~ -20%)
RECOMMENDATION:  [X] WAIT
STRONG BUY:   $7.50   (~32% below base FV)
ACCUMULATE:   $9.00   (~18% below base FV)
FAIR VALUE:   $11.00
POSITION SIZE: 0% now -> 1.5-2.5% if it reaches accumulate zone
CATALYST: ERP optimization + $70M synergies + working-capital release
PRIMARY RISK: Integration/ERP failure + energy cyclicality
SELL TRIGGER: Synergy cut, leverage >2.5x, goodwill impairment

Recommendation: WAIT. A competently run, sensibly diversified, capital-light distributor mid-way through a value-creating but risky integration — a good business at a fair price. Buffett's point is that you want a good business at a wonderful price, or you wait. Klarman's small toe-hold is reasonable for a fund that holds a basket; for a concentrated value portfolio it does not yet clear the margin-of-safety bar. Revisit at $9 (accumulate) and $7.50 (strong buy), or sooner if integration data de-risks the normalized-EBITDA case.

8.4 Munger's final test

"If this fell 50% tomorrow, would I buy more or panic?" — At ~$6.60 (DCF-base / tangible-book territory) with the integration thesis intact, I would buy enthusiastically. That answer is exactly why I should not chase it at $13.23.

9. Risk Register

# Risk Prob. Impact Monitoring metric Action threshold
1 ERP / integration failure Med (25–30%) High Combined gross-margin % trend; MRC US customer revenue 2 quarters declining GM% post-stabilization
2 Energy-capex downturn Med (20–25%) High US rig/completion counts; upstream revenue mix Sustained rig decline >15%
3 Leverage stress Low (5–8%) High Net-debt/EBITDA >2.5x without WC-release path
4 Goodwill/intangible impairment Med Medium Quarterly impairment disclosures Any impairment charge
5 Digital/marketplace disintermediation Low-Med (secular) Medium Gross-margin %, e-commerce mix Structural GM% erosion
6 Capital-allocation indiscipline Low Medium M&A cadence vs deleveraging Large debt-funded M&A pre-integration

10. Sources & Data Audit

Document Source Local path Key data extracted
10-K FY2025 (filed 2026-02-26) SEC EDGAR data/10-K-2025.htm / .txt MRC merger terms (0.9489 ratio, $1,763M price), pro-forma rev $5,274M/$5,556M & NI $10M/$17M, 186.3M shares (Feb 2026), ~5,300 employees, ~300 locations, no dividend, LIFO change, 3-segment structure
10-K FY2024 (filed 2025-02-18) SEC EDGAR data/10-K-2024.htm Prior-year standalone baseline
Income statement (14 yrs) AlphaVantage data/income-statement.json Revenue, gross profit, op income, net income FY2020–2025
Balance sheet AlphaVantage data/balance-sheet.json Equity $2,238M, goodwill $617M, intangibles $565M, current assets $2,278M, total liab $1,686M, inventory $1,192M
Cash flow AlphaVantage data/cash-flow.json OCF/capex 2020–2025 (2020 OCF +$189M in a down year = counter-cyclical proof)
Company overview AlphaVantage data/company-overview.json Market cap $2.42B, EBITDA $147M, P/S 0.71, P/B 1.10, EV/EBITDA 12.04, beta 0.84 (analyst targets NOT used)
Historical prices (3,030 records, 2014–2026) AlphaVantage data/historical-prices.json $13.23 close, 52w $11.12–16.87, vol 41%
Earnings transcript Q1 2026 AlphaVantage data/earnings-transcript-Q1-2026.md Synergies ($30M yr-1, $70M 3-yr), $455M net debt, record $50M buyback, ERP status, FY2026/2027 outlook, WC-release optionality
Earnings transcript Q4 2025 AlphaVantage data/earnings-transcript-Q4-2025.md FY2025 results, $135M inventory step-up, Adj EBITDA $209M

Cross-checks: Market cap (overview $2.42B) ≈ shares 186.3M × $13.23 = $2.46B (consistent). Net debt (transcript $455M) ≈ balance-sheet debt $571M − cash $116M (consistent). Pro-forma combined revenue (~$5.3B) consistent with mgmt FY2026 "approaching $5B" run-rate.

Data caveats: (1) AlphaVantage cash-flow JSON did not parse the buyback line — buyback figures sourced from 10-K/transcript ($167M since 2022, $50M Q1-2026). (2) AlphaVantage balance-sheet "118M shares" is a reclassified/interim figure; the authoritative post-merger count is 186.3M from the 10-K cover (Feb 18 2026). (3) FY2025 GAAP is a transition year and unrepresentative — all valuation is built on normalized combined owner earnings. (4) No PDF annual reports (10-Ks downloaded as HTML; identical content) — verify_data.py WARN on this point only (exit 2).